Dexamethasone: Clinical Trials

5 trials for Dexamethasone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 1 recruiting. 5 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 2, Unknown 2, Recruiting 1
Phase 31Completed 1

Follow Dexamethasone: new trials by email Literature Review of Dexamethasone trials Research Report on Dexamethasone

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Pre-medication With Anti-inflammatory Drugs(Ibuprofen and Dexamethasone)on Post-Endodontic Pain
Anti-inflammatory drug (ibuprofen), Anti-inflammatory drug (dexamethsaone) - Post-endodontic Pain, Ibuprofen
Phase 2RecruitingArmed Forces Institute of Dentistry, Pakistan1302025-02-152025-05-20
The Effect of Perioperative Dexamethasone Administration on Postoperative Pain in Patients Undergoing Periacetabular Osteotomy.
Dexamethasone 24mg Solution for Injection, Saline Solution for Injection - Dexamethasone, Hip Dysplasia
Phase 2 / Phase 3CompletedOdense University Hospital902020-11-122024-04-02
Perioperative Dexamethasone on Postoperative Outcome in IBD
Dexamethasone, Normal saline - Inflammatory Bowel Diseases, Dexamethasone
Phase 2CompletedJinling Hospital, China3022018-06-012021-02-11
Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Chidamide combined with R-GDP - Chidamide, Lymphoma, B-Cell
Phase 2UnknownFudan University632017-12-212017-12-14
Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma
G-CSF, Bortezomib, Cyclophosphamide - Myeloma, Bortezomib
Phase 2UnknownSecond Affiliated Hospital of Soochow University602013-12-012014-01-06

Narrower conditions

Agnosia (1)  ·  Hip Dislocation (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Inflammatory Bowel Diseases (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms, Plasma Cell (1)  ·  Pain, Postoperative (1)  ·  Postoperative Complications (1)  ·  Postoperative Nausea and Vomiting (1)

Broader conditions

Neoplasms by Histologic Type (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Digestive System Diseases (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hip Injuries (1)  ·  Intestinal Diseases (1)  ·  Joint Diseases (1)  ·  Joint Dislocations (1)  ·  Lymphoma (1)  ·  Musculoskeletal Diseases (1)  ·  Nausea (1)  ·  Neoplasms (1)

Interventions

Dexamethasone (3)  ·  Saline Solution (2)  ·  Absorptiometry, Photon (1)  ·  Anti-Inflammatory Agents (1)  ·  Bortezomib (1)  ·  Cyclophosphamide (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Ibuprofen (1)  ·  Injections (1)  ·  Sodium Chloride (1)  ·  Solutions (1)

Sponsors

Armed Forces Institute of Dentistry, Pakistan (1)  ·  Fudan University (1)  ·  Jinling Hospital, China (1)  ·  Odense University Hospital (1)  ·  Second Affiliated Hospital of Soochow University (1)

Countries

China (3)  ·  Denmark (1)  ·  Pakistan (1)

Top investigators

Jianfeng Gong, MD (1)  ·  Jinxiang Fu, M.D., PhD (1)  ·  Quratulain Abbasi, BDS (1)  ·  Viktoria Lindberg-Larsen, MD, PhD (1)

Results publications

PMID 33749741, PMID 40460271

NIH funding

2019 (1)